[1]卜祥辉,安海燕,陈莉,等.糖尿病肾病与中医体质相关性研究[J].西部中医药,2023,36(12):142-147.[doi:10.12174/j.issn.2096-9600.2023.12.32]
 BU Xianghui,AN Haiyan,CHEN Li,et al.Research on the Correlation between Diabetic Nephropathy and TCM Physique[J].Western Journal of Traditional Chinese Medicine,2023,36(12):142-147.[doi:10.12174/j.issn.2096-9600.2023.12.32]
点击复制

糖尿病肾病与中医体质相关性研究
分享到:

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
36
期数:
2023年12期
页码:
142-147
栏目:
研究进展
出版日期:
2023-12-15

文章信息/Info

Title:
Research on the Correlation between Diabetic Nephropathy and TCM Physique
作者:
卜祥辉, 安海燕, 陈莉, 赵静, 张承承, 丁昕宇
北京中医药大学东方医院,北京 100029
Author(s):
BU Xianghui, AN Haiyan, CHEN Li, ZHAO Jing, ZHANG Chengcheng, DING Xinyu
By reviewing the characteristics of TCM physique in diabetic nephropathy (DN) patients, the cause and the pathogenesis is unclear until now, and there is no radical cure, therefore, early prevention and treatment are crucial to halting the progression of the disease. Ancient physicians have early realized the key role of physique played in the onset and development of DN, emphasizing "prevention before the onse of the disease" "treatment chosen according to the variability of an individual", and modern doctors continuously improve their understanding to the theory of TCM physique, and establish theoretical system of TCM constitution, developing the important function in the prevention and treatment of DN.
关键词:
糖尿病肾病中医体质因人制宜辨识
Keywords:
diabetic nephropathyTCM physiquetreatment chosen according to the variability of an individualidentification
分类号:
R587.2
DOI:
10.12174/j.issn.2096-9600.2023.12.32
文献标志码:
A
摘要:
糖尿病肾病;中医体质;因人制宜;辨识
Abstract:
diabetic nephropathy;TCM physique;treatment chosen according to the variability of an individual;identification

相似文献/References:

[1]林晓芬,黄燕璇.益肾汤联合厄贝沙坦及胰激肽原酶治疗早期糖尿病肾病的疗效观察[J].西部中医药,2013,26(07):68.
 LIN Xiaofen,HUANG Yanxuan.Clinical Observation on YiShenTang Combined with Irbesartan and Pancreatic Kininogenase in the Treatment for Early Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2013,26(12):68.
[2]朱群邦,陈明骏,方凡夫,等.留学生抑郁情绪影响因素分析[J].西部中医药,2013,26(09):45.
 ZHU Qunbang,CHEN Mingjun,FANG Fanfu,et al.On Influencing Factors of Depression in Foreign Students[J].Western Journal of Traditional Chinese Medicine,2013,26(12):45.
[3]王学琦,李丰华,张荣华,等.温肾汤治疗早期糖尿病肾病80例[J].西部中医药,2013,26(09):62.
 WANG Xueqi,LI Fenghua,ZHANG Ronghua,et al.WenShenTang for 80 Cases of Early Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2013,26(12):62.
[4]任芳,徐厚谦△.黄芪注射液治疗糖尿病肾病有效性及安全性的系统评价[J].西部中医药,2014,27(01):77.
 REN Fang,XU Houqian.Systematic Review of the Effectiveness and Safety of HuangQi Injection in Treating Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2014,27(12):77.
[5]李盛华,周明旺,潘文,等.酒精性股骨头坏死与中医体质类型的关系*[J].西部中医药,2014,27(03):80.
 LI Shenghua,ZHOU Mingwang,PAN Wen,et al.Exploration on the Relationship between Alcohol-induced Osteonecrosis Femoral Head and TCM Constitution Types[J].Western Journal of Traditional Chinese Medicine,2014,27(12):80.
[6]樊小青,朱燕,姚宁.116例干眼症的中医体质与中医证型频数调查[J].西部中医药,2014,27(04):79.
 FAN Xiaoqing,ZHU Yan,YAO Ning.Survey on TCM Constitutions of 116 Patients with Xerophthalmia and Frequency of TCM Patterns[J].Western Journal of Traditional Chinese Medicine,2014,27(12):79.
[7]丁夏楠,许筠△,苏建平,等.益肾逐瘀方治疗糖尿病肾病蛋白尿37例[J].西部中医药,2014,27(04):96.
 DING Xianan,XU Jun,SU Jianping,et al.Treatment for Proteinuria of 37 Patients with Diabetic Nephropathy by Kidney-invigorating Stagnation-dispelling Prescription[J].Western Journal of Traditional Chinese Medicine,2014,27(12):96.
[8]肖远莉.循证护理的优效性及影响因素分析———来自终末期糖尿病肾病患者血液透析的证据[J].西部中医药,2014,27(08):127.
[9]刘涛.缬沙坦联合复方丹参滴丸对早期2型糖尿病肾病患者尿微量白蛋白的影响[J].西部中医药,2015,28(05):106.
[10]连琯,史晓伟.当归补血汤合金水宝治疗早期糖尿病肾病16例临床观察[J].西部中医药,2013,26(06):68.
 LIAN Guan,SHI Xiaowei.Clinical Observation on DangGui BuXueTang and JinShuiBao in Treating 16 Cases of Early Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2013,26(12):68.

备注/Memo

备注/Memo:
陈虎虎(1985—),男,硕士学位,讲师。研究方向:中药分子药理及抗肿瘤研究。甘肃省青年科技计划项目(20JR5RA485);庆阳市科技计划项目(QY2021A-F022);甘肃省高等学校创新基金项目(2021B-279,2020A-114)。
更新日期/Last Update: 2023-12-15